Imaging of hepatic incidentalomas with CT and MRI
Abstract
The increasing and widespread use of imaging techniques has led to an increase in the detection of incidental focal liver lesions. Most hepatic incidentalomas are benign lesions which do not require further investigation or intervention; however, few of them may prove malignant. Although conventional ultrasonography is usually the first imaging method, it lacks the diagnostic performance of multidetector computed tomography (CT) or magnetic resonance imaging (MRI) in the detection and characterisation of hepatic incidentalomas. In this review, the role of CT and MRI in the investigation of hepatic incidentalomas will be presented. The guidelines of the American College of Radiology regarding the management of focal liver lesions incidentally detected on CT will be discussed. Finally, the typical CT and MRI features of common hepatic incidentalomas, including both benign and malignant, will be reviewed.
Keywords
Full Text:
PDFReferences
Koea JB. Hepatic incidentaloma: the rule of tens. HPB (Oxford) 2013; 15(5): 379-383.
Little JM, Kenny J, Hollands MJ. Hepatic incidentaloma: a modern problem. World J Surg 1990; 14(4): 448-451.
Fergusson J. Investigation and management of hepatic incidentalomas. J Gastroenterol Hepatol 2012; 27(12): 1772-1782.
Gore RM, Pickhardt PJ, Mortele KJ, et al. Management of incidental liver lesions on CT: A white paper of the ACR Incidental Findings Committee. J Am Coll Radiol 2017; 14(11): 1429-1437.
Gore RM, Newmark GM, Thakrar KH, et al. Hepatic incidentalomas. Radiol Clin North Am 2011; 49(2): 291-322.
Hanna TN, Shekhani H, Zygmont ME, et al. Incidental findings in emergency imaging: frequency, recommendations, and compliance with consensus guidelines. Emerg Radiol 2016; 23(2): 169-174.
Belli G, D’Agostino A, Ianelli A, et al. Hepatic incidentaloma. retrospective analysis of 35 cases. Int Surg 1996; 81(2): 144-148.
Pooler BD, Kim DH, Pickhardt PJ. Indeterminate but likely unimportant extracolonic findings at screening CT colonography (C-RADS category E3): incidence and outcomes data from a clinical screening program. AJR Am J Roentgenol 2016; 207(5): 996-1001.
Pooler BD, Kim DH, Pickhardt PJ. Screening CT colonography: incidence and outcomes data from a clinical screening program. AJR Am J Roentgenol 2016; 206 (2): 313-318.
Quattrocchi CC, Giona A, Di Martino AC, et al. Extra-spinal incidental findings at lumbar spine MRI in the general population: a large cohort study. Insights Imaging 2013; 4(3): 301-308.
Choi SH, Kwon HJ, Lee SY, et al. Focal hepatic solid lesions incidentally detected on initial ultrasonography in 542 asymptomatic patients. Abdom Radiol (NY) 2016; 41: 265-272.
Nguyen XV, Davies L, Eastwood JD, et al. Extrapulmonary findings and malignancies in participants screened with chest CT in the National Lung Screening Trial. J Am Coll Radiol 2017; 14(3): 324-330.
Shuaib W, Johnson JO, Salastekar N, et al. Incidental findings detected on abdomino-pelvic multidetector computed tomography performed in the acute setting. Am J Emerg Med 2014; 32(1): 36-39.
Kelly ME, Heeney A, Redmond CE, et al. Incidental findings detected on emergency abdominal CT scans: a 1-year review. Abdom Imaging 2015; 40(6): 1853-1857.
Maxwell AW, Keating DP, Nickerson JP. Incidental abdominopelvic findings on expanded field-of-view lumbar spinal MRI: frequency, clinical importance, and concordance in interpretation by neuroimaging and body imaging radiologists. Clin Radiol 2015; 70(2): 161-167.
Morgan AE, Berland LL, Ananyev SS, et al. Extraurinary incidental findings on CT for hematuria: the radiologist’s role and downstream cost analysis. AJR Am J Roentgenol 2015; 204(6): 1160-1167.
Samim M, Goss S, Luty S, et al. Incidental findings on CT for suspected renal colic in emergency department patients: prevalence and types in 5,383 consecutive examinations. J Am Coll Radiol 2015; 12(1): 63-69.
Ather MH, Memon W, Rees J. Clinical impact of incidental diagnosis on non-contrast-enhanced helical CT for acute ureteral colic. Semin Ultrasound CT MRI 2005; 26(1): 20-23.
Semaan A, Branchi V, Marowsky AL, et al. Incidentally detected focal liver lesions-a common clinical management dilemma revisited. Anticancer Res 2016; 36(6): 2923-2932.
Pickhardt PJ, Taylor AJ. Extracolonic findings identified in asymptomatic adults at screening colonoscopy. AJR Am J Roentgenol 2006; 186(3): 718-728.
Green DE, Woodward PJ. The management of indeterminate incidental findings detected at abdominal CT. Semin Ultrasound CT MRI 2005; 26(1): 2-13.
Behbahani S, Mittal S, Patlas MN, et al. “Incidentalomas” on abdominal and pelvic CT in emergency radiology: literature review and current management recommendation. Abd Radiol (NY) 2017; 42(4):1046-1061.
Marrero JA, Ahn J, Rajender Reddy K. ACG clinical guideline: the diagnosis and management of focal liver lesions. Americal College of Gastroenterology. Am J Gastroenterol 2014; 109(9): 1328-1347.
Dietrich CF, Sharma M, Gibson RN, et al. Fortuitously discovered liver lesions. World J Gastroenterol 2013; 19(21): 3173-3188.
Hansen N, Weadock W, Morani A, et al. Liver lesions discovered incidentally on ultrasound: evaluation of reader ability to characterize lesions on MRI without intravenous contrast. Acad Radiol 2012; 19(9): 1087-1093.
Gore RM, Thakrar KH, Wenzke DR, et al. That liver lesion on MDCT in the oncology patient: is it important? Cancer Imaging 2012; 12(2): 373-384.
Ferraioli G, Dellafiore C, Meloni MF, et al. A review of the appropriateness of the current italian guidelines for noninvasive imaging assessment of focal liver lesions. J Gastrointestin Liver Dis 2015; 24(4): 491-497.
Chung YE, Kim MJ, Kim YE, et al. Characterization of incidental liver lesions: comparison of multidetector CT versus Gd-EOB-DTPA-enhanced MR imaging. PLoS One 2013; 8(6): e66141.
Soussan M, Aube C, Bahrami S, et al. Incidental focal solid liver lesions: diagnostic performance of contrast-enhanced ultrasound and MR imaging. Eur Radiol 2010; 20(7): 1715-1725.
Liu CL, Fan ST, Lo CM, et al. Hepatic resection for incidentaloma. J Gastrointest Surg 2004; 8(7): 785-793.
Harvey CJ, Albrecht T. Ultrasound of focal liver lesions. Eur Radiol 2001; 11(9): 1578-1593.
Noone TC, Semelka RC, Chaney DM, et al. Abdominal imaging studies: comparison of diagnostic accuracies resulting from ultrasound, computed tomography, and magnetic resonance imaging in the same individual. Magn Reson Imaging 2004; 22(1): 19-24.
Smajerova M, Petrasova H, Little J, et al. Contrast-enhanced ultrasonography in the evaluation of incidental focal liver lesions: A cost-effectiveness analysis. World J Gastroenterol 2016; 22(38): 8605-8614.
Semelka RC, Martin DR, Balci C, et al. Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging 2001; 13(3): 397-401.
Op de Beeck B, Luypaert R, Dujardin M, et al. Benign liver lesions: differentiation by magnetic resonance. Eur J Radiol 1999; 32(1): 52-60.
Frydrychowicz A, Lubner MG, Brown JJ, et al. Hepatobiliary MR imaging with gadolinium-based contrast agents. J Magn Reson Imaging 2012; 35(3): 492-511.
Claudon M, Dietrich CF, Choi BI, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med 2013; 34(1): 11-29.
European Association for the Study the Liver (EASL). ASL clinical practice guidelines on the management of benign liver tumours. J Hepatol 2016; 65(2): 386-398.
Strobel D, Seitz K, Blank W, et al. Contrast-enhanced ultrasound for the characterization of focal liver lesions-diagnostic accuracy in clinical practice (DEGUM multicenter trial). Ultraschall Med 2008; 29(5): 499-505.
Tranquart F, Fayault A, Le Gouge A, et al. Role of contrast-enhanced ultrasound in the blinded assessment of focal liver lesions in comparison with MDCT and CEMRI: Results from a multicentre clinical trial. EJC Suppl 2008; 6(11): 9-15.
Trillaud H, Bruel JM, Valette PJ, et al. Characterization of focal liver lesions with SonoVue-enhanced sonography: international multicenter-study in comparison to CT and MRI. World J Gastroenterol 2009; 15(30): 3748-3756.
Seitz K, Bernatik T, Strobel D, et al. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI-a prospective comparison in 269 patients. Ultraschall Med 2010; 31(5): 492-499.
Albrecht T, Blomley M, Bolondi L, et al. Guidelines for the use of contrast agents in ultrasound. Ultraschall Med 2004; 25(4): 249-256.
Friedrich-Rust M, Klopffleisch T, Nierhoff J, et al. Contrast-enhanced ultrasound for the differentiation of benign and malignant focal liver lesions: a meta-analysis. Liver Int 2013; 33(5):739-755.
Kaur H, Hindman NM, Al-Refaie WB, et al. ACR Appropriateness criteria® suspected liver metastases. J Am Coll Radiol 2017; 14(5S): S314-S325.
Grassetto G, Marzola MC, Chondrogiannis S, et al. Potential role of FDG PET/CT in evaluating patients with hepatic incidentalomas. Clin Nucl Med 2014; 39(2): 156-159.
Ros P, Erturk SM. Benign tumors of the liver. In: Gore RM, Levine MS (ed). Textbook of Gastrointestinal Radiology. Elsevier, Philadelphia 2015, pp 1608-1628.
Benign Liver Lesions. In: Lencioni R, Cioni D, Bartolozzi C (ed). Focal liver lesions: detection, characterization, ablation (Medical Radiology/Diagnostic Imaging). Springer-Verlag, Berlin Heidelberg 2005, pp 73-166.
Ji H, Ros PR. Benign liver tumors. In: Gourtsoyiannis NC, Ros PR (ed). Radiologic-pathologic correlations. From head to toe. Springer-Verlag, Berlin Heidelberg 2005, pp 343-366.
Lewis RB, Lattin GE Jr, Makhlouf HR, et al. Tumors of the liver and intrahepatic bile ducts: radiologic-pathologic correlation. Magn Reson Imaging Clin N Am 2010; 18(3): 587-609.
BaSsalamah A, Baroud S, Bastati N, et al. MR imaging of benign focal liver lesions. Magn Reson Imaging Clin N Am 2010; 18(3): 403-419.
Cogley JR, Miller FH. MR imaging of benign focal liver lesions. Radiol Clin North Am 2014; 52(4): 657-682.
Chiche L, Adam JP. Diagnosis and management of benign liver tumors. Semin Liver Dis 2013; 33(3): 236-247.
Gaines PA, Sampson MA. The prevalence and characterization of simple hepatic cysts by ultrasound examination. Br J Radiol 1989; 62(736): 335-337.
Borhani AA, Wiant A, Heller MT. Cystic hepatic lesions: a review and an algorithmic approach. AJR Am J Roentgenol 2014; 203(6): 1192-204.
Pitchaimuthu M, Duxbury M. Cystic lesions of the liver-A review. Curr Probl Surg 2017; 54(10): 514-542.
Mavilia MG, Pakala T, Molina M, et al. Differentiating cystic liver lesions: a review of imaging modalities, diagnosis and management. J Clin Transl Hepatol 2018; 6(2): 208-216.
Yoon SS, Charny CK, Fong Y, et al. Diagnosis, management, and outcomes of 115 patients with hepatic hemangioma. J Am Coll Surg 2003; 197(3): 392-402.
Kamaya A, Maturen KE, Tye GA, et al. Hypervascular liver lesions. Semin Ultrasound CT MRI 2009; 30(5): 387-407.
Silva AC, Evans JM, McCullough AE, et al. MR imaging of hypervascular liver masses: a review of current techniques. Radiographics 2009; 29(2): 385-402.
Ronot M, Vilgrain V. Imaging of benign hepatocellular lesions: current concepts and recent updates. Clin Res Hepatol Gastroenterol 2014; 38(6): 681-688.
Burgio MD, Ronot M, Salvaggio G, et al. Imaging of hepatic focal nodular hyperplasia: pictorial review and diagnostic strategy. Semin Ultrasound CT MR 2016; 37(6): 511-524.
Cristiano A, Dietrich A, Spina JC, et al. Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management. Updates Surg 2014; 66(1): 9-21.
Grazioli L, Bondioni MP, Haradome H, et al. Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 2012; 262(2): 520-529.
Goodwin MD, Dobson JE, Sirlin CB, et al. Diagnostic challenges and pitfalls in MR imaging with hepatocyte-specific contrastagents. Radiographics 2011; 31(6): 1547-1568.
Campos JT, Sirlin CB, Choi JY. Focal hepatic lesions in Gd-EOB-DTPA enhanced MRI: the atlas. Insights Imaging 2012; 3(5): 451-474.
McInnes MD, Hibbert RM, Inácio JR, et al. Focal nodular hyperplasia and hepatocellular adenoma: accuracy of gadoxetic acid enhanced MR imaging-a systematic review. Radiology 2015; 277(2): 413-423.
Merkle EM, Zech CJ, Bartolozzi C, et al. Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging. Eur Radiol 2016; 26(3): 674-682.
Yoneda N, Matsui O, Kitao A, et al. Benign hepatocellular nodules: hepatobiliary phase of gadoxetic acid-enhanced MR imaging based on molecular background. Radiographics 2016; 36(7): 2010-2027.
Dharmana H, Saravana-Bawan S, Giris S, et al. Hepatocellular adenoma: imaging review of the various molecular subtypes. Clin Radiol 2017; 72(4): 276-285.
Hussain SM, van den Bos IC, Dwarkasing RS, et al. Hepatocellular adenoma: findings at state-of-the-art magnetic resonance imaging, ultrasound, computed tomography and pathologic analysis. Eur Radiol 2006; 16(9): 1873-1886.
Grazioli L, Federle MP, Brancatelli G, et al. Hepatic adenomas: imaging and pathologic findings. Radiographics 2001; 21(4): 877-892.
Chung KY, Mayo-Smith WW, Saini S, et al. Hepatocellular adenoma: MR imaging features with pathologic correlation. AJR Am J Roentgenol 1995; 165(2): 303-308.
Anderson SW, Kruskal JB, Kane RA. Benign hepatic tumors and iatrogenic pseudotumors. Radiographics 2009; 29(1): 211-229.
Desser TS. Understanding transient hepatic attenuation differences. Semin Ultrasound CT MRI 2009; 30(5): 408-417.
Jang JK, Jang HJ, Kim JS, et al. Focal fat deposition in the liver: diagnostic challenges on imaging. Abdom Radiol (NY) 2017; 42(6): 1667-1678.
Vogel A, Cervantes A, Chau I, et al. Hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2018; 29(4): iv238-iv255.
Elsayes KM, Kielar AZ, Elmohr MM, et al. White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI. Abdom Radiol (NY) 2018; 43(10): 2625-2642.
Jiang HY, Chen J, Xia CC, et al. Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis. World J Gastroenterol 2018; 24(22): 2348-2362.
Ayuso C, Rimola J, Vilana R, et al. Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines. Eur J Radiol 2018; 101: 72-81.
Park MJ, Kim YK, Lee MW, et al. Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns. Radiology 2012; 264(3): 761-770.
Guo J, Seo Y, Ren S, et al. Diagnostic performance of contrast-enhanced multidetector computed tomography and gadoxetic acid disodium-enhanced magnetic resonance imaging in detecting hepatocellular carcinoma: direct comparison and a meta-analysis. Abdom Radiol (NY) 2016; 41(10): 1960-1972.
Park G, Kim YK, Kim CS, et al. Diagnostic efficacy of gadoxetic acid-enhanced MRI in the detection of hepatocellular carcinomas: comparison with gadopentetate dimeglumine. Br J Radiol 2010; 83(996): 1010-1016.
Ahn SS, Kim MJ, Lim JS, et al. Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma. Radiology 2010; 255(2): 459-466.
Han JK, Choi BI, Kim AY, et al. Cholangiocarcinoma: pictorial essay of CT and cholangiographic findings. Radiographics 2002; 22(1): 173-187.
Seo N, Kim DY, Choi JY. Cross-sectional imaging of intrahepatic cholangiocarcinoma: development, growth, spread, and prognosis. AJR Am J Roentgenol 2017; 209(2): W64-W75.
Weber SM, Ribero D, O’Reilly EM, et al. Intrahepatic cholangiocarcinoma: expert consensus statement. HPB (Oxford) 2015; 17(8): 669-680.
Joo I, Lee JM, Yoon JH. Imaging diagnosis of intrahepatic and perihilar cholangiocarcinoma: recent advances and challenges. Radiology 2018; 288(1): 7-13.
Karaosmanoglu AD, Onur MR, Ozmen MN, et al. Magnetic resonance imaging of liver metastasis. Semin Ultrasound CT MR 2016; 37(6): 533-548.
DOI: http://dx.doi.org/10.36162/hjr.v4i2.260
Refbacks
- There are currently no refbacks.